DNM1L and Miyoshi myopathy: Defects in mitochondrial dynamics have been also reported in hematological malignancies, as T-cell acute lymphoblastic leukemia and MM [15, 16], which enhance the expression and/or activity of fission proteins, like Drp1, to promote survival and resistance to chemotherapy.